Abstract
Purpose
To evaluate the influence of boost irradiation for breast conserving therapy on skin and subcutaneous tissue.
Materials and Methods
Between 1989 and 1995, 468 patients were treated with breast conserving surgery (quadrantectomy or wide excision with axillary dissection) followed by 50 Gy whole breast irradiation. Among them, fifty-eight patients with positive or close margins were treated with 10 Gy external beam boost irradiation. Skin and subcutaneous soft tissue changes during 5-years of follow-up were examined by inspection and palpation and evaluated using the BCT follow-up form based on EORTC late effect toxicity scoring.
Result
Four percent (20/468) of the patients showed grade 2 late changes in skin and soft tissue. Four of them had skin telangiectasis, which was limited to within the boost field. Boost irradiation had no definite influence on other late changes. Patients’ age, extent of surgery, and pT size had no significant relation to the late changes. The cosmetic score 5 years after BCT was not significantly different between the patients with and without boost irradiation.
Conclusion
Although 10 Gy boost irradioation after 50 Gy whole breast irradiation increased skin telangiectasis, the late skin and soft tissue changes caused by the boost irradiation were generally mild and there was no substantial deterioration of cosmetic outcome.
Similar content being viewed by others
Abbreviations
- BCT:
-
Breast conserving therapy
- BRA:
-
Breast retraction assesment
- DCIS:
-
Ductal carcinomain situ
References
Sarrazin D, Le MG, Arriagada R,et al: Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer.Radiother Oncol 14: 177–184, 1989.
van Dongen JA, Bartelink H, Fentiman IS,et al: Randomized clinical trial to assess the value of breastconserving therapy in stage I and II breast cancer, EORTC 10801 trial.J Natl Cancer Inst Monogr 11: 15–18, 1992.
Blichert-Toft M, Rose C, Andersen JA,et al: Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis. Danish Breast Cancer Cooperative Group.J Natl Cancer Inst Monogr 11: 19–25, 1992.
Fisher B, Anderson S, Redmond CK,et al: Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer.N Engl J Med 333: 1456–1461, 1995.
Romestaing P, Lehingue Y, Carrie C,et al: Role of a 10-Gy boost in the conservative treatment of early breast cancer: results of a randomized clinical trial in Lyon, France.J Clin Oncol 15: 963–968, 1997.
Bartelink: Recurrence rate after treatment of breast cancer with standard radiotherapy with or without additional radiation.N Engl J Med 345: 1378–1387, 2001.
Kondo M, Amemiya A: Role of irradiation in breast conservation therapy for breast cancer.Nippon Igaku Hoshasen Gakkai Zasshi 59: 839–843, 1999.
Habibollahi F, Mayles HM, Mayles WP,et al: Assessment of skin dose and its relation to cosmesis in the conservative treatment of early breast cancer.Int J Radiat Oncol Biol Phys 14: 291–296, 1988.
Taylor ME, Perez CA, Halverson KJ,et al: Factors influencing cosmetic results after conservation therapy for breast cancer.Int J Radiat Oncol Biol Phys 31: 753–764, 1995.
Hiraoka M, Mitsumori M, Okajima K,et al: Use of a CT simulator in radiotherapy treatment planning for breast conserving therapy.Radiother Oncol 33: 48–55, 1994.
Kokubo M, Mitsumori M, Yamamoto C,et al: Impact of boost irradiation with surgically placed radiopaque clips on local control in breast-conserving therapy.Breast Cancer 8: 222–228, 2001.
Harris: Analysis of cosmetic results following primary radiation therapy for stages I and II carcinoma of the breast.Int J Radiation Oncology Biol Phys 5: 257–261, 1979.
Pezner RD, Wagman LD, Ben-Ezra J,et al: Breast conservation therapy: local tumor control in patients with pathologically clear margins who receive 5000 cGy breast irradiation without local boost.Breast Cancer Res Treat 32: 261–267, 1994.
Pavy JJ, Denekamp J, Letschert J, Littbrand B, Mornex F, Bernier J, Gonzales-Gonzales D, Horiot JC, Bolla M, Bartelink H: EORTC Late Effects Working Group. Late effects toxicity scoring: the SOMA scale.Radiother Oncol 35: 11–15, 1995.
Vrieling C, Collette L, Fourquet A,et al: The influence of the boost in breast-conserving therapy on cosmetic outcome in the EORTC “boost versus no boost” trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups. European Organization for Research and Treatment of Cancer.Int J Radiat Oncol Biol Phys 45: 677–685, 1999.
Fujishiro S, Mitsumori M, Kokubo M,et al: Cosmetic results and complications after breast conserving therapy for early breast cancer.Breast Cancer 7: 57–63, 2000.
Borger JH, Kemperman H, Smitt HS,et al: Dose and volume effects on fibrosis after breast conservation therapy.Int J Radiat Oncol Biol Phys 30: 1073–1081, 1994.
Author information
Authors and Affiliations
Additional information
Reprint requests to Setsuko Okumura, Department of Radiology, Hyogo Prefectural Amagasaki Hospital, 1-1-1 Higashidaimotsucho, Amagasaki, Hyogo 660-0828, Japan.
About this article
Cite this article
Okumura, S., Mitsumori, M., Kokubo, M. et al. Late skin and subcutaneous soft tissue changes after 10-Gy boost for breast conserving therapy. Breast Cancer 10, 129–133 (2003). https://doi.org/10.1007/BF02967637
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02967637